Dudnik, E.
282  Ergebnisse:
Personensuche X
?
1

133TiP Neoadjuvant osimertinib followed by sequential defin..:

Kian, W. ; Peled, N. ; Roisman, L.C....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S115 , 2023
 
?
3

P2.16-05 Durvalumab+EP in Advanced Large-Cell Neuroendocrin..:

Dudnik, E. ; Ariel, L. ; Hod, K....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S376-S377 , 2023
 
?
4

P1.21-14 LIPI-based Score Predicting OS Benefit for the Add..:

Raphael, A. ; Kamm Feldman, A. ; Kian, W....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S240 , 2023
 
?
5

EP08.02-122 Real-world Experience with Capmatinib in MET Ex..:

Illini, O. ; Fabikan, H. ; Swalduz, A....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S460 , 2022
 
?
6

EP08.02-047 The Impact of CGP on the Decision-making Proces..:

Dudnik, E. ; Raphael, A. ; Holtzman, L....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S419-S421 , 2022
 
?
 
?
8

The analysis of the lateral refraction influence during the..:

Dudnik, A E ; Samsonova, N V ; Tupoleva, G K.
IOP Conference Series: Materials Science and Engineering.  913 (2020)  4 - p. 042022 , 2020
 
?
9

Clinical activity of brigatinib in ROS1-rearranged non-smal..:

the Israel Lung Cancer Group ; Dudnik, E. ; Agbarya, A....
Clinical and Translational Oncology.  22 (2020)  12 - p. 2303-2311 , 2020
 
?
10

Automation of data processing processes:

Dudnik, A E ; Germak, O V ; Tupoleva, G K
IOP Conference Series: Materials Science and Engineering.  698 (2019)  - p. 044006 , 2019
 
?
 
?
14

6022 POSTER Plasma Levels of Heparanase as Marker of Tumour..:

Dudnik, E. ; Kuten, A.
European Journal of Cancer.  47 (2011)  - p. S398 , 2011
 
1-15